Humana faces backlash for hiking breast cancer drug copays

(By Morgan Haefner for Becker’s Hospital Review)

Humana recently reclassified Herceptin — an intravenous drug used to treat metastatic breast cancer — as a nonpreferred drug in some Florida markets, CBS12 reports. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or


Leave a Reply